Pulmonary Fibrosis Clinical Trials

A research study exploring new ways to slow lung scarring and improve breathing in pulmonary fibrosis.

Pulmonary Fibrosis Research Study

Are you living with pulmonary fibrosis and want to learn more about available research options? Our study coordinators are here to answer your questions and guide you if idiopathic pulmonary fibrosis clinical trials may be right for you.

Contact Us Today

Questions or Interested in a Trial?

This field is for validation purposes and should be left unchanged.

Join Pulmonary Fibrosis Research Study

Pulmonary fibrosis is a chronic lung condition where scar tissue gradually forms in the lungs, making them stiff and reducing their ability to function properly. Over time, this leads to ongoing shortness of breath, fatigue, and difficulty with daily activities.

Frequently Asked Questions

Find answers to common questions about eligibility, participation, and what to expect.

All participant information is handled with strict confidentiality, following HIPAA guidelines, secure data systems, and encrypted records to ensure privacy and protection throughout the study.

Our site conducts multiple stages of research, including Phase II, III, and IV clinical trials, helping evaluate safety, effectiveness, and long-term outcomes of potential treatments.

Once a study concludes, participants may receive a final health evaluation, and results are carefully reviewed to help guide future research and improve care options. Participants are also transitioned back to their regular healthcare providers if needed.

Participants in pulmonary fibrosis research study may receive close medical monitoring, specialized research care, and access to investigational treatments.

Yes, participation is completely voluntary. You may withdraw from pulmonary fibrosis clinical trials at any time without affecting your regular medical care or future treatment options.